Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-743 Extended Treatment Study in Patients with Leigh Syndrome
jRCT2080222577Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of vatiquinone in Leigh syndrome, sponsored by Sumitomo Pharma. Started Aug 2014; status: completed.
02
Drugs
vatiquinone
03
Conditions
Leigh syndrome
Beyond the preview
Go deeper on jRCT2080222577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222577.